<bill session="118" type="s" number="689" updated="2025-07-21T19:32:26Z">
  <state datetime="2023-03-07">REFERRED</state>
  <status>
    <introduced datetime="2023-03-07"/>
  </status>
  <introduced datetime="2023-03-07"/>
  <titles>
    <title type="display">A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001288"/>
  <cosponsors>
    <cosponsor bioguide_id="B001236" joined="2023-09-12"/>
    <cosponsor bioguide_id="B001310" joined="2023-09-11" withdrawn="2023-09-12"/>
    <cosponsor bioguide_id="F000479" joined="2023-09-11"/>
    <cosponsor bioguide_id="P000603" joined="2023-03-07"/>
    <cosponsor bioguide_id="S001191" joined="2024-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-03-07" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-02T18:48:51Z" status="Introduced in Senate">This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)</summary>
</bill>
